Cancer Treatment News and Research

RSS

A.P. Pharma enters into definitive agreements for $24M private placement of common stock and warrants

A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that it has entered into definitive agreements with certain new and existing accredited investors providing for a private placement of common stock and warrants in which the Company will receive $24 million in gross proceeds.

29 Jun 2011

Some adult survivors of childhood cancer are at risk for multiple cancers

The largest study yet of adult childhood cancer survivors found that the first cancer is just the beginning of a lifelong battle against different forms of the disease for about 10 percent of these survivors.

29 Jun 2011

Women can benefit from immediate breast reconstruction following mastectomy

For women undergoing mastectomy for breast cancer, immediate breast reconstruction has a low risk of complications—including serious complications related to radiation therapy—and does not cause undue delays in cancer treatment, reports a study in the July issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.

28 Jun 2011

Chaos in biochemical alterations of cancer cells

Using the latest gene sequencing tools to examine so-called epigenetic influences on the DNA makeup of colon cancer, a Johns Hopkins team says its results suggest cancer treatment might eventually be more tolerable and successful if therapies could focus on helping cancer cells get back to normal in addition to strategies for killing them.

27 Jun 2011

Enrollment complete in ERYTECH Pharma's Graspa Phase I clinical trial for pancreatic cancer

ERYTECH Pharma has just completed the enrollment of patients in a Phase I clinical trial with its flagship product for pancreatic cancer, Graspa®. This product contains the enzyme L-asparaginase encapsulated in red blood cells, using technology owned by ERYTECH Pharma.

27 Jun 2011

Longer looks: Prenatal care for dads; rise in bipolar diagnosis for children

Perhaps it's because mom has the burgeoning belly, but dads have largely been left out of prenatal care. That could be damaging to the family's health, contends research in a recent issue of the Journal of Advanced Nursing.

24 Jun 2011

Varian receives 2011 R&D 100 Award for TrueBeam system for image-guided radiotherapy and radiosurgery

Varian Medical Systems today announced that the company's TrueBeam system for image-guided radiotherapy and radiosurgery has received a 2011 R&D 100 Award from R&D Magazine. This annual award salutes the 100 most technologically significant products of the prior year, spanning many categories, from biomedical products to consumer items.

23 Jun 2011

CPDC, UHN to advance use of medical isotopes for cancer treatment and diagnosis

CanProbe, a unique, not-for-profit joint venture to advance the use of medical isotopes for diagnosing and treating cancer and other serious diseases, was announced today by the Centre for Probe Development and Commercialization (CPDC) and the University Health Network.

23 Jun 2011

Novel method of disguising nanoparticles as red blood cells to fight cancer

Researchers at the University of California, San Diego have developed a novel method of disguising nanoparticles as red blood cells, which will enable them to evade the body's immune system and deliver cancer-fighting drugs straight to a tumor. Their research was published this week in the online Early Edition of the Proceedings of the National Academy of Sciences.

22 Jun 2011

The Hormone Foundation releases 'SaveMyFertility' website for cancer patients

For the first time ever, young adults and the parents of children diagnosed with cancer—and the physicians who treat them—have a comprehensive, bilingual resource to give them critically important guidance about preserving their fertility before and during cancer treatment.

21 Jun 2011

Initiation of ALD518/BMS-945429 Phase 2b clinical trial in RA triggers milestone payment to Alder

Alder Biopharmaceuticals Inc. today announced it will receive a $15 million milestone payment from Bristol-Myers Squibb for the initiation of a Phase 2b clinical trial in rheumatoid arthritis for ALD518/BMS-945429, an investigational antibody therapeutic that blocks interleukin-6 (IL-6).

20 Jun 2011

Novel vaccine approach for prostate cancer

Mayo Clinic investigators and collaborators from the United Kingdom cured well-established prostate tumors in mice using a human vaccine with no apparent side effects. This novel cancer treatment approach encourages the immune system to rid itself of prostate tumors without assistance from toxic chemotherapies and radiation treatments.

20 Jun 2011

Genentech to present positive data from vismodegib Phase II trial on advanced BCC at EADO 2011

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that positive data are being presented by its collaborator Genentech, a member of the Roche Group, from a pivotal Phase II clinical trial conducted by Roche and Genentech of vismodegib in patients with advanced basal cell carcinoma, an often life-threatening form of skin cancer that can have disfiguring and debilitating effects.

20 Jun 2011

Controversy over F.D.A.-Avastin decision to reignite June 28-29 with new round of hearings

Controversy over the F.D.A.'s proposal to withdraw approval of Avastin for breast cancer treatment will reignite June 28-29 with a new round of hearings. One oncologist who will be monitoring the hearings is Dr. Frederick C. Tucker Jr. of Fredericksburg Oncology in Virginia, whose recent New York Times op ed defended the F.D.A.'s position on scientific grounds.

18 Jun 2011

Nuvilex describes advantages of cell encapsulation technology for multiple cancer therapies

Nuvilex, Inc. described today potential advantages of cell encapsulation technology for use in cancer therapies when more than one cancer-fighting drug is used.

17 Jun 2011

New Australian drug shows positive response in patients with multiple myeloma blood cancer

Australian monoclonal antibody company, Immune System Therapeutics Limited (IST), today announced it would double patient recruitment in its Phase II trial for a breakthrough antibody treatment for terminal blood cancer.

16 Jun 2011

State roundup: Mass. health spending's rise; huge Ky. hospital merger

A new report from the state Division of Health Care Finance and Policy shows that: ... "Spending per member on privately insured people grew 6 percent from 2007 to 2008 and another 10 percent from 2008 to 2009. This rate of growth was substantially higher than the increase in national personal health care expenditures per capita of 4.6 percent from 2008 to 2009. Spending by private payers also grew faster than spending by public payers".

16 Jun 2011

Varian receives marketing approval for TrueBeam image-guided radiotherapy and radiosurgery system in Japan

Varian Medical Systems, Inc., the world's leading manufacturer of medical technology for treating cancer with radiotherapy, announced today it has received Shonin approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market the TrueBeam™ system for image-guided radiotherapy and radiosurgery in Japan.

15 Jun 2011

Nuvilex to acquire live cell encapsulation technology for multiple cancer therapies

Nuvilex, Inc. announced today it has entered into discussions to acquire the next generation live cell encapsulation technology that serves as the platform for multiple cancer therapies.

15 Jun 2011

Biomoda receives U.S. patent to expand the use of CyPath assay for treatment of cancer

Cancer diagnostics company Biomoda, Inc. received Notice of Allowance for a U.S. Patent issued today that expands on use of the CyPath assay to include patient response to cancer therapy during the treatment phase of the disease.

15 Jun 2011

Cancer Treatment News and Research

A.P. Pharma enters into definitive agreements for $24M private placement of common stock and warrants

Some adult survivors of childhood cancer are at risk for multiple cancers

Women can benefit from immediate breast reconstruction following mastectomy

Chaos in biochemical alterations of cancer cells

Enrollment complete in ERYTECH Pharma's Graspa Phase I clinical trial for pancreatic cancer

Longer looks: Prenatal care for dads; rise in bipolar diagnosis for children

Varian receives 2011 R&D 100 Award for TrueBeam system for image-guided radiotherapy and radiosurgery

CPDC, UHN to advance use of medical isotopes for cancer treatment and diagnosis

Novel method of disguising nanoparticles as red blood cells to fight cancer

The Hormone Foundation releases 'SaveMyFertility' website for cancer patients

Initiation of ALD518/BMS-945429 Phase 2b clinical trial in RA triggers milestone payment to Alder

Novel vaccine approach for prostate cancer

Genentech to present positive data from vismodegib Phase II trial on advanced BCC at EADO 2011

Controversy over F.D.A.-Avastin decision to reignite June 28-29 with new round of hearings

Nuvilex describes advantages of cell encapsulation technology for multiple cancer therapies

New Australian drug shows positive response in patients with multiple myeloma blood cancer

State roundup: Mass. health spending's rise; huge Ky. hospital merger

Varian receives marketing approval for TrueBeam image-guided radiotherapy and radiosurgery system in Japan

Nuvilex to acquire live cell encapsulation technology for multiple cancer therapies

Biomoda receives U.S. patent to expand the use of CyPath assay for treatment of cancer

Cancer Research eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News